The composition and signaling of the IL-35 receptor are unconventional

Nature Immunology

Volumn 13, Issue 3, 2012, Pages 290-299

  Collison, Lauren W ^a   Delgoffe, Greg M ^a   Guy, Clifford S ^a   Vignali, Kate M ^a   Chaturvedi, Vandana ^a   Fairweather, Delisa ^b   Satoskar, Abhay R ^c   Garcia, K Christopher ^d   Hunter, Christopher A ^e   Drake, Charles G ^f   Murray, Peter J ^a   Vignali, Dario A A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; HETERODIMER; HOMODIMER; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 35; INTERLEUKIN 35 RECEPTOR; INTERLEUKIN RECEPTOR; PROTEIN EBI3; PROTEIN P35; STAT1 PROTEIN; STAT4 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE REPRESSION; GENETIC CODE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CYTOKINE RECEPTOR GP130; INTERLEUKINS; MICE; MICE, KNOCKOUT; MODELS, MOLECULAR; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-12; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR;

EID: 84857193362     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2227     Document Type: Article

References (50)

1. Vignali, D.A., Collison, L.W. & Workman, C.J. How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532 (2008).
2. Zou, W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6, 295-307 (2006).
3. O'Shea, J.J. & Paul, W.E. Regulation of TH1 differentiation- controlling the controllers. Nat. Immunol. 3, 506-508 (2002).
4. Artis, D. et al. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173, 5626-5634 (2004). (Pubitemid 39392150)
5. Awasthi, A. et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380-1389 (2007). (Pubitemid 350131175)
6. Fitzgerald, D.C. et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8, 1372-1379 (2007). (Pubitemid 350131174)
7. Stumhofer, J.S. et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363-1371 (2007). (Pubitemid 350131173)
8. Collison, L.W. et al. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093-1101 (2010).
9. Collison, L.W., Pillai, M.R., Chaturvedi, V. & Vignali, D.A. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35-and IL-10-dependent manner. J. Immunol. 182, 6121-6128 (2009).
10. Collison, L.W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569 (2007). (Pubitemid 350190247)
11. Chua, A.O., Wilkinson, V.L., Presky, D.H. & Gubler, U. Cloning and characterization of a mouse IL-12 receptor-β component. J. Immunol. 155, 4286-4294 (1995).
12. Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699-5708 (2002). (Pubitemid 34556153)
13. Pflanz, S. et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172, 2225-2231 (2004). (Pubitemid 38182370)
14. Silver, J.S. & Hunter, C.A. gp130 at the nexus of inflammation, autoimmunity, and cancer. J. Leukoc. Biol. 88, 1145-1156 (2010).
15. Bacon, C.M. et al. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 92, 7307-7311 (1995).
16. Delgoffe, G.M., Murray, P.J. & Vignali, D.A. Interpreting mixed signals: the cell's cytokine conundrum. Curr. Opin. Immunol. 23, 1-7 (2011).
17. Thierfelder, W.E. et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174 (1996). (Pubitemid 26242884)
18. Huber, M. et al. IL-27 inhibits the development of regulatory T cells via STAT3. Int. Immunol. 20, 223-234 (2008). (Pubitemid 351234390)
19. Owaki, T. et al. STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production. J. Immunol. 180, 2903-2911 (2008).
20. Wu, C. et al. IL-12 receptor β 2 (IL-12Rβ2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites. J. Immunol. 165, 6221-6228 (2000).
21. Presky, D.H. et al. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 93, 14002-14007 (1996).
22. Villarino, A. et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19, 645-655 (2003). (Pubitemid 37490790)
23. Schroers, A. et al. Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane. Protein Sci. 14, 783-790 (2005). (Pubitemid 40283917)
24. Skiniotis, G., Lupardus, P.J., Martick, M., Walz, T. & Garcia, K.C. Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex. Mol. Cell 31, 737-748 (2008).
25. Betz, U.A. & Muller, W. Regulated expression of gp130 and IL-6 receptor α chain in T cell maturation and activation. Int. Immunol. 10, 1175-1184 (1998). (Pubitemid 28362692)
26. Charlot-Rabiega, P., Bardel, E., Dietrich, C., Kastelein, R. & Devergne, O. Signaling events involved in interleukin 27 (IL-27)-induced proliferation of human naive CD4+ T cells and B cells. J. Biol. Chem. 286, 27350-27362 (2011).
27. Hibbert, L., Pflanz, S., De Waal Malefyt, R. & Kastelein, R.A. IL-27 and IFN-α signal via Stat1 and Stat3 and induce T-bet and IL-12Rβ2 in naive T cells. J. Interferon Cytokine Res. 23, 513-522 (2003). (Pubitemid 37130074)
28. Takeda, A. et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170, 4886-4890 (2003). (Pubitemid 36554716)
29. Liao, W., Lin, J.X., Wang, L., Li, P. & Leonard, W.J. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat. Immunol. 12, 551-559 (2011).
30. O'Shea, J.J. & Murray, P.J. Cytokine signaling modules in inflammatory responses. Immunity 28, 477-487 (2008). (Pubitemid 351467044)
31. Ho, H.H. & Ivashkiv, L.B. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J. Biol. Chem. 281, 14111-14118 (2006). (Pubitemid 43848338)
32. Yamamoto, K., Miura, O., Hirosawa, S. & Miyasaka, N. Binding sequence of STAT4: STAT4 complex recognizes the IFN-γ activation site (GAS)-like sequence (T/A)TTCC(C/G)GGAA(T/A). Biochem. Biophys. Res. Commun. 233, 126-132 (1997). (Pubitemid 27215922)
33. Ehret, G.B. et al. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J. Biol. Chem. 276, 6675-6688 (2001).
34. Yu, Q., Thieu, V.T. & Kaplan, M.H. Stat4 limits DNA methyltransferase recruitment and DNA methylation of the IL-18Rα gene during Th1 differentiation. EMBO J. 26, 2052-2060 (2007). (Pubitemid 46625788)
35. Ramsauer, K. et al. Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-γ-inducible gbp2 gene. Proc. Natl. Acad. Sci. USA 104, 2849-2854 (2007). (Pubitemid 46327968)
36. Boulanger, M.J., Chow, D.C., Brevnova, E.E. & Garcia, K.C. Hexameric structure and assembly of the interleukin-6/IL-6 α-receptor/gp130 complex. Science 300, 2101-2104 (2003). (Pubitemid 36760138)
37. Stern, A.S., Gubler, U., Presky, D.H. & Magram, J. Structural and functional aspects of the IL-12 receptor complex. Chem. Immunol. 68, 23-37 (1997). (Pubitemid 27420357)
38. Huyton, T. et al. An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor. Proc. Natl. Acad. Sci. USA 104, 12737-12742 (2007). (Pubitemid 47255224)
39. Lucas, S., Ghilardi, N., Li, J. & de Sauvage, F.J. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and-independent mechanisms. Proc. Natl. Acad. Sci. USA 100, 15047-15052 (2003). (Pubitemid 37518014)
40. Canda-Sánchez, A. et al. Differential distribution of both IL-12Rβ chains in the plasma membrane of human T cells. J. Membr. Biol. 227, 1-12 (2009).
41. Maldonado, R.A., Irvine, D.J., Schreiber, R. & Glimcher, L.H. A role for the immunological synapse in lineage commitment of CD4 lymphocytes. Nature 431, 527-532 (2004). (Pubitemid 39336325)
42. Szabo, S.J., Dighe, A.S., Gubler, U. & Murphy, K.M. Regulation of the interleukin (IL)-12Rβ2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185, 817-824 (1997). (Pubitemid 27119865)
43. Grohmann, U. et al. IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production. Immunity 9, 315-323 (1998). (Pubitemid 28462752)
44. Andersson, J. et al. CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-β-dependent manner. J. Exp. Med. 205, 1975-1981 (2008).
45. Pot, C. et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183, 797-801 (2009).
46. Pistoia, V., Cocco, C. & Airoldi, I. Interleukin-12 receptor β2: from cytokine receptor to gatekeeper gene in human B-cell malignancies. J. Clin. Oncol. 27, 4809-4816 (2009).
47. Hirschfield, G.M. et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N. Engl. J. Med. 360, 2544-2555 (2009).
48. Matsui, E. et al. Mutations of the IL-12 receptor β2 chain gene in atopic subjects. Biochem. Biophys. Res. Commun. 266, 551-555 (1999). (Pubitemid 30028704)
49. Remmers, E.F. et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease. Nat. Genet. 42, 698-702 (2010).
50. Xu, Y. et al. Crystal structure of the entire ectodomain of gp130: insights into the molecular assembly of the tall cytokine receptor complexes. J. Biol. Chem. 285, 21214-21218 (2010).